Canada markets close in 2 hours 25 minutes

Celldex Therapeutics, Inc. (CLDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
44.61+0.90 (+2.07%)
As of 1:34PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close43.70
Open43.69
Bid44.59 x 1200
Ask44.72 x 800
Day's Range43.22 - 45.05
52 Week Range9.66 - 46.42
Volume167,497
Avg. Volume825,482
Market Cap2.072B
Beta (5Y Monthly)3.06
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
  • Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
    GlobeNewswire

    Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

    HAMPTON, N.J., July 16, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the closing of its previously announced underwritten public offering of 6,845,238 shares of its common stock, which includes the exercise in full by the underwriters of their option to purchase an additional 892,857 shares, at a public offering price of $42.00 per share. The gross proceeds to Celldex from this offering were approximately $287.5 million, before d

  • Celldex Therapeutics Announces Pricing of Upsized $250 Million Public Offering of Common Stock
    GlobeNewswire

    Celldex Therapeutics Announces Pricing of Upsized $250 Million Public Offering of Common Stock

    HAMPTON, N.J., July 13, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the pricing of an underwritten public offering of 5,952,381 shares of its common stock at a public offering price of $42.00 per share. In connection with the offering, Celldex has granted the underwriters a 30-day option to purchase up to an additional 892,857 shares of common stock at the public offering price, less underwriting discounts and commissions. Jeffe

  • Celldex Therapeutics Announces Proposed Public Offering of Common Stock
    GlobeNewswire

    Celldex Therapeutics Announces Proposed Public Offering of Common Stock

    HAMPTON, N.J., July 12, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced that it is proposing to offer and sell, subject to market conditions, $175 million of shares of its common stock in an underwritten public offering. Celldex expects to grant the underwriters a 30-day option to purchase up to an additional $26.25 million of shares of common stock offered in the public offering. All of the shares of common stock are being offered